Peak poised to enter market with $21m series C:
This article was originally published in Clinica
Executive Summary
Peak Surgical, a Palo Alto, California-based developer of tissue dissection systems, has raised $21m in a series C financing led by new investor Signet Healthcare Partner. The proceeds will enable Peak to commence commercialisation of its flagship product, the Peak surgery system, which incorporates the firm's pulsed plasma technology. The company is awaiting 510(k) clearance from the US FDA for the product and has begun setting up a nationwide sales team, as well as manufacturing for the Peak PlasmaBlade, an integral part of the surgery system.